446

The EUGOGO 20th Anniversary Meeting
International Symposium on Graves\' Orbitopathy

The EUGOGO 20th Anniversary Meeting
International Symposium on Graves\' Orbitopathy

Datum
07.11.2019, 12:00 - 09.11.2019, 13:00
Symposium
Pisa
Sprache
Englisch
Gebühren ab
450.00 EUR
Veranstalter
European Group on Graves` Orbitopathy (EUGOGO)
Endocrine Unit, Department of Medical Sciences University of Milan via Sforza 35,
Organisator

A.I.C. Asti lncentives & Congressi 
Piazza San Uomobono 30 
56126 Pisa
Phone: +39 050 598808 
Fax: +39 050 0987825


Organizer : 

European Group on Graves` Orbitopathy (EUGOGO)
Endocrine Unit, Department of Medical Sciences
University of Milan
Via Sforza 35
Secretary Dr. Mario Salvi

  • Basisinformation
    Datum
    07.11.2019, 12:00 - 09.11.2019, 13:00
    Symposium
    Pisa
    Sprache
    Englisch
    Gebühren ab
    450.00 EUR
    Veranstalter
    European Group on Graves` Orbitopathy (EUGOGO)
    Endocrine Unit, Department of Medical Sciences University of Milan via Sforza 35,
    Organisator

    A.I.C. Asti lncentives & Congressi 
    Piazza San Uomobono 30 
    56126 Pisa
    Phone: +39 050 598808 
    Fax: +39 050 0987825


    Organizer : 

    European Group on Graves` Orbitopathy (EUGOGO)
    Endocrine Unit, Department of Medical Sciences
    University of Milan
    Via Sforza 35
    Secretary Dr. Mario Salvi

  • VERANSTALTUNGSORT
    Camera di Commercio di Pisa
    Piazza Vittorio Emanuele II 5
    56125 Pisa, IT
  • Programm

     

      SCIENTIFIC  PROGRAM Thursday, November the 7th, 2019
    12:00 - 13:00 Registration Opening Ceremony
    13:00 - 13:15 Opening Ceremony
    13:20 - 13:30 Tomb of Sarteano: the first GO painting in history
      Lelio Baldeschi (Brussels), Maurizio Martinelli (Firenze)
    13:30 - 13:50 Mark Prummel memorial lecture
      Chairperson: Claudio Marcocci (Pisa)
      EUGOGO achievements over 20 years - Wilmar Wiersinga (Amsterdam)
    13:55 - 15:35 Symposium 1: the lmmunopathogenesis of GO in 2019
      Chairpersons: Paul Banga (London), Marvin Gershengorn (Bethesda) 
    13:55 - 14:15  Genetics and epigenetics of GO - Simon Pearce (Newcastle upon Tyne)
    14:15 - 14:35  Role of fibrocytes in GO - Terry Smith (Ann Arbor)
    14:35 - 14:55 Overview of the immune response in GO - Wilfern A.  Dik (Amsterdam)
    14:55 - 15:15 The microbioma in Graves' disease and GO - Marian Ludgate (Cardiff) 
    15:15 - 15:35 Graves' disease and GO following immune reconstitution Ilaria Muller (Cardiff) 
    15:40 - 16:40 Oral Presentations 1
      Chairpersons: Nicola Curro (Milan),  Michele Marino (Pisa)
    16:40 - 17:00 Coffee Break
    17:00 - 18:40 Symposium 2: diagnostic issues on GO phenotypes
       Chairpersons: Chistoph Hintschich (Munich), Ray Douglas (Los Angeles) 
    17:00 - 17:20  Unilateral, hypothyroid and euthyroid GO - Anja Eckstein (Essen)
    17:20 - 17:40  Orbital volumetry and its significance - Wilmar Wiersinga (Amsterdam)
    17:40 - 18:00 IgG4-related disease, the inflammatory neophyte in the orbit /lse Mombaerts (Leuven)
    18:00 - 18:20 Differential diagnosis of GO: the importance of multidisciplinarity and specialized centers - Lelio Baldeschi (Brussels)
    18:20 - 18:40 Diagnostic criteria and management of optic neuropathy - Antonella Boschi (Brussels)
    18:45 - 19:05 George von Arx memorial lecture
      Chairperson: Lelio Baldeschi (Brussels)
      The importance of the ophthalmologist and of the joint clinic in GO / Nicole Fichter (Olfen)
    19:05 - 20:00 Welcome  Cocktail

     

     

      SCIENTIFIC  PROGRAM Friday, November the 8th, 2019
    8:30 - 8:50 Aldo Pinchera memorial lecture
      Chairperson: Paolo Vitti (Pisa)
      Epidemiology and secular trends of GO - Petros Perros (Newcastle upon Tyne)
    8:55 - 9:15 Symposium 3: anlmal models of GD and GO
      Chairpersons:  Marian Ludgate (Cardiff),  Gerd Krause (Berlin)
    8:55 - 9:15 Epitope peptides derived from the TSH receptor as an effective treatment in a mouse model of Graves' disease and GO - Martin Ungerer (Bavaria)
      The "English" model - Paul Banga (London)
    9:35 - 9:55 The "German" model - Utta Berchner-Pfannshmidt (Essen)
    10:00 - 11:00 Oral Presentations 2
      Chairpersons: Katharina Ponto (Mainz),  Milos iarkovic (Beigrade)
    11:00 - 11:20 Coffee Break
    11:20 - 12:40 Symposium 4: ophthalmologlcal controversles and unmet needs
      Chairpersons: Kostas Boboridis (Thessanoliki), Co/in Dayan (Cardiff)
    11:20 - 11:40 EUGOGO consensus on eye motility assessment - Nicola Curro (Milan)
    11:40 - 12:00 Assessment of primary and secondary outcomes of immunosuppressive treatment of active GO - Luigi Bartalena (Varese)
    12:00 - 12:40 DEBATE: ls CAS always a reliable tool to define GO activity?
      Pro: Lucy Clark (Newcastle upon Tyne)
      Cons: Peter Dolman (Vancouver) 
    12:40 - 14:15 Lunch and  Poster viewing
    14:15 - 15:35 Symposium 5: from pathogenesis to medical treatment: focus on the TSH receptor
      Chairpersons: George Kahaly (Mainz),  Terry Smith (Ann Arbour)
    14:15 - 14:35 TSH receptor and signaling pathways - Gerd Krause (Berlin)
    14:35 - 14:55 TSH receptor and lgF-1 receptor interactions - Marvin Gershengorn (Bethesda)
    14:55 - 15.15  Small molecules antagonists as potential new agents for therapeutic targeting of the TSH receptor - Susanne Neumann (Bethesda)
    15:15 - 15:35 TSH receptor monoclonal blocking antibodies - Wisia Furmaniak (Cardiff)
    15:40 - 16:40 Symposium 6 (Part 1 ): old and novel treatment modalltles
      Chairpersons: Mario Sa/vi (Milan),  Nichole Fichter (O/ten)
    15:40 - 16:00  lntravenous glucocorticoids - C/audio Marcocci (Pisa) 
    16:00 - 16:20 Selenium - Michele Marino (Pisa)
    16:20 - 16:40 Mycophenolate (The MINGO Study) - George Kahaly (Mainz)
    16:40 - 17:00 Coffee Break
    17:00 - 18:35 Symposium 6 (Part 2): Old and novel treatment modallties
      Chairpersons: Simon Pearce (Newcastle upon Tyne), Anja Eckstein (Essen) 
    17:00 - 17:20 Combined immunosuppression and radiotherapy (The CIRTED study) Peter N. Taylor (Cardiff)
    17:20 - 17:40 Teprotumumab - Ray Douglas (Los Angeles)
    17:40 - 18:00 Rituximab and other B cell targeting options - Mario Salvi (Milano) 
    18:00 - 18:20 Tocilizumab - Jose V.  Perez-Moreiras (Santiago de Compostela)
    18:20 - 18:50 lnteractive Discussion on Symposium 6
      Chairmen:  Luigi Bartalena (Varese)
    18:20 - 18:25 Chairperson's summary
    18:25 - 18:50 lnteractive discussion
    20:30 - 23:30 Network Dinner
       
       
      SCIENTIFIC  PROGRAM Saturday, November the 9th, 2019
    8:30 - 9:50 Symposium 7: ophthalmic perspectives
      Chairpersons: Marco Nardi (Pisa),  Peter Dolman (Vancouver)
    8:30 - 8:50 Orbital decompression: does the approach matter? A review of the literature - Christoph Hintschich (Munich)
    8:50 - 9:10 Outcome measures for strabismus surgery - Branislav Stancovic (Be/grade)
    9:10 - 9:30 Treatment of eyelids and tear film alteration in GO - Kostas Boboridis (Thessaloniki)
    9:30 - 9:50  Nanotechnology applied to Graves' Orbitopathy: a potential alternative to more invasive medical and surgical treatments - Djon Paridaens (Rotterdam) 
    9:55 - 10:55 Oral Presentations 3
      Chairpersons: Goksun Ayvaz (Ankara),  Antonella Boschi (Brussels) Coffee  Break
    10:55 . 11:15 Coffee  Break
    11:15 - 12:05 Patient Forum
      Chairpersons: Dan Morris (Cardiff), Petros Perros (Newcastle upon Tyne)
    11:15 - 12:05 The quality of life in GO and the impact of GO in public health - Katharina Ponto (Mainz)
    11:35 - 11:55 My life with GO - Janis Hickey (British Thyroid Foundation)
    11:55 - 12:15 lmplementing change for improving the care of patients with GO: the TEAMED paradigm - Co/in Dayan (Cardiff)
    12:15 - 12:35 Lecture
      Chairperson: Wilmar Wiersinga (Amsterdam)
      Quo vadis GO? - Marius Stan (USA)
    12:40 - 1:00 Closing Ceremony

     

    Deadlines
    Abstract
    10.08.2019
    Hinweis
    Abstract submission for oral and poster presentations are welcome - At least one author per abstract must be registered prior to abstract submission. In all other cases abstracts will be rejected -Acceptance or rejection will be confirmed by August 30th -Abstract should be no longer than 300 words, and should include Title, First and Last name of the authors separated by commas, affiliation/s of the authors -No images or pictures are allowed -Abstracts should be organized into the following sections: Background, Methods, Results, Conclusions.
  • Gebühren
    Fachärzte/-innen
    Gebühren ab
    450,00 EUR
    Price for EUGOGO members : € 350,00

    ACCOMPANYING PERSONS
    (includes Welcome Reception at the Congress Venue and Congress Dinner) - € 160,00
  • Buchung / Anmeldung

    Please contact A.I.C. Asti lncentives & Congressi for futher information.

  • Zertifizierung
    Keine Zertifizierung beantragt
  • Sponsoren
    EYEFOX.com sind bislang keine Sponsoren oder Aussteller bekannt. Wenn Sie die Veranstaltung als Sponsor oder Aussteller unterstützen, ergänzen wir das gerne kostenfrei.

Veranstaltung teilen